Humacyte Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	48.54	50.5	44.94	80.45	149.77	217.5
Short-Term Investments	-	-	-	-	2.11	8
Cash & Short-Term Investments	48.54	50.5	44.94	80.45	151.88	225.5
Cash Growth	-22.77%	12.37%	-44.14%	-47.03%	-32.65%	464.76%
Accounts Receivable	0.43	0.44	-	-	0.03	0.18
Inventory	9.92	13.59	-	-	-	-
Other Current Assets	4.91	3.48	53.13	3.04	2.3	3.66
Total Current Assets	63.6	67.8	47.86	83.28	154.21	229.34
Net Property, Plant & Equipment	46.08	47.69	38.55	44.1	49.41	57.19
Other Long-Term Assets	0.88	0.88	51.46	0.84	0.68	-
Total Assets	110.56	116.37	137.87	128.22	204.3	286.53
Accounts Payable	5.08	5.4	4.49	6.49	1.6	2.09
Accrued Expenses	8.68	10.54	11.42	9.34	7.11	6.76
Short-Term Debt	-	-	0.89	-	8.57	-
Current Portion of Long-Term Debt	-	-	-	-	8.57	-
Current Portion of Leases	2.43	2.43	2.92	2.56	2.31	2.03
Other Current Liabilities	-	-	1.12	0.05	-	0.17
Total Current Liabilities	16.19	18.37	19.95	18.44	19.58	11.05
Long-Term Debt	35.87	35.44	63.35	38.6	20.34	27.36
Long-Term Leases	27.6	26.97	13.62	16.29	18.85	21.79
Other Long-Term Liabilities	19.27	32.47	156.97	79.94	28.61	104.16
Total Long-Term Liabilities	82.75	94.89	233.94	134.83	67.79	153.31
Total Liabilities	98.93	113.26	190.54	114.68	87.37	164.36
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-in Capital	756.07	729.94	633.33	550.85	543.46	536.74
Retained Earnings	-744.47	-726.85	-686.02	-537.31	-426.54	-414.57
Shareholders' Equity	11.62	3.11	-52.67	13.55	116.93	122.17
Total Liabilities & Equity	110.56	116.37	137.87	128.22	204.3	286.53
Total Debt	65.9	64.85	80.78	57.45	58.64	51.18
Net Cash (Debt)	-17.36	-14.35	-35.84	23	93.24	174.32
Net Cash Growth	-	-	-	-75.34%	-46.51%	1923.02%
Net Cash Per Share	-0.10	-0.09	-0.30	0.22	0.91	4.36
Book Value	11.62	3.11	-52.67	13.55	116.93	122.17
Book Value Per Share	0.07	0.02	-0.44	0.13	1.13	3.06
Tangible Book Value	11.62	3.11	-52.67	13.55	116.93	122.17
Tangible Book Value Per Share	0.07	0.02	-0.44	0.13	1.13	3.06

SEC Filings: 10-K · 10-Q